UK: Declarations Of Non-Infringement And Prosecution History – UK Court Of Appeal Rules In Actavis V Eli Lilly

Last Updated: 24 August 2015
Article by Beth Williams

In a judgment that clarifies key areas of patent law, the UK Court of Appeal has overturned a decision by the High Court to award declarations of non-infringement (DNIs) to Actavis, clarifying the UK position on the use of the prosecution history in patent cases and the applicable rules for applying for a foreign DNI.

In this case, the DNIs were awarded in respect of Actavis' pemetrexed dipotassium, pemetrexed diacid and pemetrexed ditromethamine products on the grounds that they did not infringe Lilly's Swiss-form patent EP 1 313 508 for the use of pemetrexed disodium in combination with vitamin B (the Patent). The first instance judgment was particularly important because Arnold J decided that Actavis were entitled to DNIs in respect of the Spanish, French and Italian designations of the Patent.

The Court of Appeal agreed with Arnold J on some issues: that the Actavis products did not directly infringe the Patent and that the UK Court were not prevented from granting Spanish, French and Italian DNIs by the Rome II Regulation. However, crucially for Lilly, the Court of Appeal held that Actavis' products would indirectly infringe the Patent. Finally, although it did not impact on the judgment in hand, the Court of Appeal made the important finding that, contrary to Arnold J's first instance decision, the prosecution history of a patent should not be a factor in legal proceedings.

  • Direct and indirect infringement

The direct infringement issue was whether the wording 'pemetrexed disodium' in the Patent's claims limited the scope of their protection to pemetrexed disodium only, or whether the Patent could cover the Actavis' pemetrexed products. Floyd J agreed with Arnold J's decision. A key deciding factor was that the specification only contained data for pemetrexed disodium and so broader claims would lack support. There was also a striking contrast between the specificity of pemetrexed disodium and the general terms used in the claim for the methyl malonic acid lowering agent and folic acid compounds, which had been referred to as any 'pharmaceutical derivative' and any 'physiologically available salt or ester thereof' respectively.

The Court then turned to whether there had been indirect infringement under section 60(2) of the Patents Act 1977. It had to decide whether Actavis' supply of its pemetrexed compounds to doctors and pharmacists was an essential means that enabled the invention to be put into effect. Lilly argued that it was, because the Actavis products would be reconstituted and diluted in saline solution, which was a source of sodium ions. Thus, both pemetrexed ions and sodium ions would be present. Lilly argued that this process mirrors what happens when the patented product is reconstituted.

Actavis argued that third parties reconstituting their products with saline would not be using pemetrexed in the manufacture of a medicament, which was the requirement under the Patent's Swiss-form claims. At first instance, Arnold J had found this argument persuasive. However, the Court of Appeal disagreed. It held that the skilled team would understand that pemetrexed disodium could refer to solutions containing pemetrexed ions and sodium ions and that, therefore, "section 60(2) does not require the supply of an element of the claim, but a means relating to an essential element. A means for releasing pemetrexed ions into solution related to an essential element of the invention where the invention called for pemetrexed ions and sodium ions in solution, particularly as it is the presence of the pemetrexed ions in the manufactured medicament which is essential for its efficacy as a medicament."

  • Prosecution history

A key issue at first instance was whether the Court should consider the prosecution history of a patent when deciding on issues of infringement. Arnold J acknowledged that "courts should be cautious before relying on prosecution history as an aid to construction" but considered that, in reality, someone who is looking to determine a patent's scope and who is professionally advised would consult the prosecution file. He held that "consideration of the prosecution file may assist in ensuring that patentees do not abuse the system by accepting narrow claims during prosecution and then arguing for a broad construction of those claims for the purpose of infringement". This finding appeared to be at odds with Lord Hoffman's judgment in Kirin-Amgen that a patent should be construed according to what the person skilled in the art would understand its claims to mean and that that meaning "should not change according to whether or not the person skilled in the art has access to the file".

Floyd LJ, giving the lead judgment in this case, disagreed with Arnold J. He did not think that a skilled person would always read the prosecution history to construe the patent. Neither did he agree with Actavis' argument that the prosecution file could assist the Court in preventing a patentee abusing the system by revealing when a patentee who was arguing for a broad construction of its patent had during prosecution argued for a narrower construction. Floyd LJ also commented that he would not have found it necessary to go to the prosecution history in order to read the conclusion on direct infringement.

  • The Rome II Regulation question

The Court then turned to the question of whether Actavis was entitled to seek the foreign DNIs from the English Court under the Rome II Regulation. Actavis had won this point at first instance and, despite deciding not to grant the DNIs, the Court dealt with it nevertheless, on the grounds that it was "potentially a point of some importance".

The issue was this: if Actavis satisfied the English test for a DNI (lex fori), was it also entitled to a DNI under Spanish, French and Italian law as well? Actavis said yes, whilst Lilly counter-argued that Actavis must instead fulfil the procedural requirements of the applicable foreign law in the designated states (lex causae) and that this had not been done.

Under Article 1(1) of the Regulation, its rules apply "in situations involving a conflict of laws, to non-contractual obligations in civil and commercial matters". Actavis relied upon Article 1(3), which explicitly excludes the Regulation's application to "evidence and procedure", to claim that the Regulation did not apply to DNIs because they were matters of procedure. They argued that lex fori was the applicable law because, under private international principles, lex fori governs procedure. Lilly argued that DNIs were a matter of non-contractual obligations. They relied on Article 8(1) of the Regulation, which says that "the law applicable to a non-contractual obligation arising from an infringement of an intellectual property right shall be the law of the country itself."

Floyd J found that Arnold J had been correct to decide that the conditions for applying for a DNI are procedural and, as such, lex fori applies to them. This is because they are "conditions of admissibility of actions, rather than rules concerned with the substance or content of parties' rights".

What Next?

Actavis has come up with a plan to sidestep the Court of Appeal's judgment. The Dublin-headquartered multinational is asking the High Court to grant the DNIs on the basis that it will direct users of its product to reconstitute it in a dextrose solution rather than a saline solution. In the meantime, the dispute has clarified the UK Court's position on the use of the prosecution history in patent cases and the applicable rules for applying for a foreign DNI.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.